Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jazz Pharmaceuticals - 17 Year Stock Price History | JAZZ

Historical daily share price chart and data for Jazz Pharmaceuticals since 2007 adjusted for splits and dividends. The latest closing stock price for Jazz Pharmaceuticals as of April 30, 2024 is 110.75.
  • The all-time high Jazz Pharmaceuticals stock closing price was 193.02 on July 28, 2015.
  • The Jazz Pharmaceuticals 52-week high stock price is 146.70, which is 32.5% above the current share price.
  • The Jazz Pharmaceuticals 52-week low stock price is 106.61, which is 3.7% below the current share price.
  • The average Jazz Pharmaceuticals stock price for the last 52 weeks is 126.03.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Jazz Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 119.7110 126.9300 132.7700 107.1000 110.7500 -9.96%
2023 135.0766 156.3600 160.4700 114.2600 123.0000 -22.79%
2022 149.4266 131.0100 168.6600 126.5900 159.3100 25.05%
2021 154.8860 160.4000 186.4200 119.8700 127.4000 -22.81%
2020 128.2596 148.4300 165.0500 87.7400 165.0500 10.56%
2019 133.7751 125.1300 153.7300 117.6500 149.2800 20.43%
2018 157.7279 137.4000 183.1800 115.9400 123.9600 -7.94%
2017 143.3267 111.4600 162.0100 111.4600 134.6500 23.50%
2016 129.6499 137.2600 157.1600 96.7400 109.0300 -22.43%
2015 165.3651 163.4300 193.0200 121.9400 140.5600 -14.15%
2014 152.3077 126.7800 183.0300 124.6300 163.7300 29.37%
2013 75.9082 54.5800 126.7900 52.7900 126.5600 137.67%
2012 48.9650 38.5900 59.3400 38.5900 53.2501 37.85%
2011 33.3224 19.9600 46.8000 19.4300 38.6300 96.29%
2010 10.9546 8.2400 20.0000 7.1500 19.6800 149.75%
2009 4.2554 2.0000 10.3700 0.5500 7.8800 308.29%
2008 7.3328 14.8000 15.4600 1.0100 1.9300 -86.87%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.982B $3.834B
Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Sativex is approved in the U.K. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. It received approval for two new drugs' Zepzelca & Rylaze'.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.830B 29.93
Chugai Pharmaceutical (CHGCY) Japan $52.113B 23.29
Takeda Pharmaceutical (TAK) Japan $41.396B 6.71
Merck (MKGAF) Germany $20.808B 19.63
Astellas Pharma (ALPMY) Japan $17.282B 27.29
Sandoz Group AG (SDZNY) Switzerland $14.602B 0.00
Shionogi (SGIOY) Japan $13.688B 12.28
Neurocrine Biosciences (NBIX) United States $13.686B 56.83
United Therapeutics (UTHR) United States $10.396B 11.81
Catalent (CTLT) United States $10.107B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.755B 0.00
Revolution Medicines (RVMD) United States $6.356B 0.00
Ionis Pharmaceuticals (IONS) United States $6.014B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.342B 0.00
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.451B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.803B 0.00
Summit Therapeutics (SMMT) United States $2.759B 0.00
PTC Therapeutics (PTCT) United States $2.466B 0.00
Corcept Therapeutics (CORT) United States $2.427B 24.55
Indivior (INDV) United States $2.421B 11.48
Dyne Therapeutics (DYN) United States $2.181B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.947B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.857B 11.00
Evotec AG (EVO) Germany $1.839B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.835B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.819B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.776B 18.35
Avadel Pharmaceuticals (AVDL) Ireland $1.645B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.597B 27.95
Ardelyx (ARDX) United States $1.497B 0.00
Soleno Therapeutics (SLNO) United States $1.492B 0.00
Xencor (XNCR) United States $1.291B 0.00
4D Molecular Therapeutics (FDMT) United States $1.224B 0.00
Pacira BioSciences (PCRX) United States $1.221B 12.15
Ironwood Pharmaceuticals (IRWD) United States $1.213B 11.40
Collegium Pharmaceutical (COLL) United States $1.208B 7.43
Cronos Group (CRON) Canada $1.123B 0.00
Cassava Sciences (SAVA) United States $0.958B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.919B 0.00
Relay Therapeutics (RLAY) United States $0.863B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.852B 0.00
ARS Pharmaceuticals (SPRY) United States $0.843B 0.00
Sage Therapeutics (SAGE) United States $0.839B 0.00
Enliven Therapeutics (ELVN) United States $0.817B 0.00
USANA Health Sciences (USNA) United States $0.799B 12.94
Ocular Therapeutix (OCUL) United States $0.733B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.728B 0.00
Silence Therapeutics (SLN) United Kingdom $0.654B 0.00
Savara (SVRA) United States $0.633B 0.00
Siga Technologies (SIGA) United States $0.624B 9.24
Exscientia (EXAI) United Kingdom $0.598B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.594B 0.00
Lyell Immunopharma (LYEL) United States $0.553B 0.00
OmniAb (OABI) United States $0.520B 0.00
Verve Therapeutics (VERV) United States $0.504B 0.00
KalVista Pharmaceuticals (KALV) United States $0.479B 0.00
ProKidney (PROK) United States $0.474B 0.00
Altimmune (ALT) United States $0.464B 0.00
Korro Bio (KRRO) United States $0.456B 0.00
Larimar Therapeutics (LRMR) United States $0.440B 0.00
Lexeo Therapeutics (LXEO) United States $0.410B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.410B 0.00
Tourmaline Bio (TRML) United States $0.406B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.389B 0.00
Esperion Therapeutics (ESPR) United States $0.373B 0.00
Nature's Sunshine Products (NATR) United States $0.366B 20.47
Harrow (HROW) United States $0.361B 0.00
Heron Therapeutics (HRTX) United States $0.349B 0.00
Fractyl Health (GUTS) United States $0.324B 0.00
Lyra Therapeutics (LYRA) United States $0.315B 0.00
Bioventus (BVS) United States $0.314B 0.00
Organogenesis (ORGO) United States $0.310B 58.75
Aquestive Therapeutics (AQST) United States $0.306B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.295B 0.00
Black Diamond Therapeutics (BDTX) United States $0.293B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.291B 0.00
ESSA Pharma (EPIX) Canada $0.284B 0.00
Nanobiotix S.A (NBTX) France $0.275B 0.00
Nektar Therapeutics (NKTR) United States $0.268B 0.00
Akebia Therapeutics (AKBA) United States $0.264B 0.00
Metagenomi (MGX) United States $0.263B 0.00
Pyxis Oncology (PYXS) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.259B 0.00
Adherex Technologies (FENC) United States $0.249B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Foghorn Therapeutics (FHTX) United States $0.232B 0.00
Conduit Pharmaceuticals (CDT) United States $0.222B 0.00
Galectin Therapeutics (GALT) United States $0.217B 0.00
Avita Medical (RCEL) United States $0.217B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Acrivon Therapeutics (ACRV) United States $0.206B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Eliem Therapeutics (ELYM) United States $0.197B 0.00
Telomir Pharmaceuticals (TELO) United States $0.196B 0.00
Century Therapeutics (IPSC) United States $0.189B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.184B 0.00
Incannex Healthcare (IXHL) Australia $0.183B 0.00
Profound Medical (PROF) Canada $0.182B 0.00
MediWound (MDWD) Israel $0.177B 0.00
Prelude Therapeutics (PRLD) United States $0.159B 0.00
Regulus Therapeutics (RGLS) United States $0.151B 0.00
Achieve Life Sciences (ACHV) Canada $0.150B 0.00
CytoDyn (CYDY) United States $0.139B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 12.97
Cardiol Therapeutics (CRDL) Canada $0.137B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.123B 2.59
Karyopharm Therapeutics (KPTI) United States $0.120B 0.00
Citius Pharmaceuticals (CTXR) United States $0.119B 0.00
GlycoMimetics (GLYC) United States $0.116B 0.00
FibroGen (FGEN) United States $0.111B 0.00
Relmada Therapeutics (RLMD) United States $0.110B 0.00
Inotiv (NOTV) United States $0.099B 0.00
OptiNose (OPTN) United States $0.093B 0.00
PMV Pharmaceuticals (PMVP) United States $0.093B 0.00
AlloVir (ALVR) United States $0.091B 0.00
Vivani Medical (VANI) United States $0.089B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.085B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Assertio Holdings (ASRT) United States $0.084B 6.81
ProPhase Labs (PRPH) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Journey Medical (DERM) United States $0.074B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.95
Mural Oncology (MURA) Ireland $0.063B 0.00
Jaguar Animal Health (JAGX) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
Surrozen (SRZN) United States $0.034B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
CASI Pharmaceuticals (CASI) China $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.031B 0.00
DURECT (DRRX) United States $0.030B 0.00
NRx Pharmaceuticals (NRXP) United States $0.027B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.67
TherapeuticsMD (TXMD) United States $0.022B 0.00
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Avalo Therapeutics (AVTX) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.04
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.23